Tekmira Provides Periodic Update on TKM-Ebola Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. QGEN

Go back to Tekmira Provides Periodic Update on TKM-Ebola Program

Tekmira Pharma (TKMR) Commences Limited GMP Manufacture of Guinea-Variant Ebola Therapeutic

October 22, 2014 6:29 AM EDT

Tekmira Pharma (Nasdaq: TKMR) provides an update on its Ebola program. The Company is reporting it has commenced limited GMP manufacture of a new therapeutic specifically targeting the Ebola Guinea variant, which is the viral variant responsible for the Ebola epidemic currently prevalent in West Africa. Supply of this new product will be available in early December, 2014, for potential use by various collaborators. As definitive agreements are established we will provide updates accordingly.

The genomic sequence of the Ebola virus responsible for the current outbreak in West Africa has been determined from several... More